2016 Hematological Malignancies

805 / 1835

+
CD49b CD8a
NT Depleted
CD49b CD4
CD49b CD8a
0 25 50 75 100
0
20
40
60
80
100
NT
5x2Gy RT + αB7-H1 10mg/kg 3qw
5x2Gy RT + αB7-H1 + αCD8 mAb
5x2Gy RT + αB7-H1 + αCD4 mAb
5x2Gy RT + αB7-H1 + αAGM1 mAb
Time after tumour
innoculation (days)
Percent survival